TriSalus Life Sciences PE Ratio 2021-2025 | TLSI
Current and historical p/e ratio for TriSalus Life Sciences (TLSI) from 2021 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. TriSalus Life Sciences PE ratio as of May 23, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
TriSalus Life Sciences PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2025-05-23 | 5.56 | 0.00 | |
2025-03-31 | 5.52 | $-1.12 | 0.00 |
2024-12-31 | 5.01 | $-1.33 | 0.00 |
2024-09-30 | 4.61 | $-2.49 | 0.00 |
2024-06-30 | 5.52 | $-2.50 | 0.00 |
2024-03-31 | 9.75 | $-2.29 | 0.00 |
2023-12-31 | 8.45 | $-1.69 | 0.00 |
2023-09-30 | 5.12 | $-0.13 | 0.00 |
2023-06-30 | 10.48 | 0 | 0.00 |
2023-03-31 | 10.20 | 0 | 0.00 |
2022-12-31 | 10.03 | 0 | 0.00 |
2022-09-30 | 9.93 | 0 | 0.00 |
2022-06-30 | 9.85 | 0 | 0.00 |
2022-03-31 | 9.80 | 0 | 0.00 |
2021-12-31 | 9.88 | 0 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.173B | $0.029B |
TriSalus Life Sciences Inc. is an oncology company integrating immunotherapy with disruptive delivery technology to transform the treatment paradigm for patients with liver and pancreatic tumors. TriSalus Life Sciences Inc., formerly known as MedTech Acquisition Corporation, is based in CHICAGO. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $228.788B | 27.51 |
Boston Scientific (BSX) | United States | $154.602B | 38.70 |
Stryker (SYK) | United States | $144.385B | 30.19 |
EssilorLuxottica (ESLOY) | France | $135.514B | 0.00 |
Medtronic (MDT) | Ireland | $103.771B | 14.71 |
Haleon (HLN) | United Kingdom | $49.845B | 28.36 |
Lonza Group Ag (LZAGY) | Switzerland | $48.977B | 0.00 |
ResMed (RMD) | United States | $35.996B | 27.04 |
GE HealthCare Technologies (GEHC) | United States | $31.796B | 15.10 |
Agilent Technologies (A) | United States | $31.270B | 20.66 |
Terumo (TRUMY) | Japan | $27.864B | 36.19 |
Insulet (PODD) | United States | $22.590B | 88.67 |
Koninklijke Philips (PHG) | Netherlands | $21.684B | 15.59 |
Zimmer Biomet Holdings (ZBH) | United States | $18.137B | 11.65 |
Baxter (BAX) | United States | $15.534B | 11.60 |
Smith & Nephew SNATS (SNN) | United Kingdom | $12.438B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
Demant (WILYY) | Denmark | $8.637B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $6.181B | 21.51 |
Lantheus Holdings (LNTH) | United States | $5.172B | 13.05 |
Prestige Consumer Healthcare (PBH) | United States | $4.201B | 18.77 |
Perrigo (PRGO) | Ireland | $3.629B | 9.20 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
ICU Medical (ICUI) | United States | $3.218B | 23.73 |
Haemonetics (HAE) | United States | $3.178B | 14.48 |
Envista Holdings (NVST) | United States | $2.859B | 23.76 |
GN Store Nord (GNNDY) | Denmark | $2.097B | 17.37 |
QuidelOrtho (QDEL) | United States | $2.041B | 14.04 |
LeMaitre Vascular (LMAT) | United States | $1.788B | 39.96 |
AtriCure (ATRC) | United States | $1.624B | 0.00 |
Neogen (NEOG) | United States | $1.343B | 17.19 |
Acuren (TIC) | United States | $1.288B | 0.00 |
AdaptHealth (AHCO) | United States | $1.206B | 12.25 |
Green Thumb Industries (GTBIF) | United States | $1.175B | 26.43 |
Kestra Medical Technologies (KMTS) | United States | $1.145B | 0.00 |
BioLife Solutions (BLFS) | United States | $1.050B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.933B | 11.93 |
InMode (INMD) | Israel | $0.906B | 9.13 |
CeriBell (CBLL) | United States | $0.624B | 0.00 |
Evolus (EOLS) | United States | $0.616B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.584B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.558B | 0.00 |
Owens & Minor (OMI) | United States | $0.532B | 4.41 |
Valneva SE (VALN) | France | $0.529B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.496B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.450B | 0.00 |
Surmodics (SRDX) | United States | $0.417B | 0.00 |
Canopy Growth (CGC) | Canada | $0.355B | 0.00 |
SNDL (SNDL) | Canada | $0.344B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.336B | 0.00 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.318B | 11.71 |
Aurora Cannabis (ACB) | Canada | $0.309B | 54.90 |
Sanara MedTech (SMTI) | United States | $0.275B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.258B | 21.73 |
Sanuwave Health (SNWV) | United States | $0.247B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.244B | 0.00 |
Cerus (CERS) | United States | $0.239B | 0.00 |
ZimVie (ZIMV) | United States | $0.233B | 10.57 |
Biote (BTMD) | United States | $0.205B | 5.77 |
Brainsway (BWAY) | Israel | $0.197B | 52.15 |
OraSure Technologies (OSUR) | United States | $0.192B | 0.00 |
High Tide (HITI) | Canada | $0.189B | 0.00 |
Omeros (OMER) | United States | $0.189B | 0.00 |
Quanterix (QTRX) | United States | $0.188B | 0.00 |
Organigram Global (OGI) | Canada | $0.183B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.174B | 14.20 |
FitLife Brands (FTLF) | United States | $0.131B | 16.18 |
Exagen (XGN) | United States | $0.128B | 0.00 |
Jin Medical (ZJYL) | China | $0.124B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.117B | 0.00 |
Agape ATP (ATPC) | $0.112B | 0.00 | |
MacroGenics (MGNX) | United States | $0.100B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
Fonar (FONR) | United States | $0.087B | 11.17 |
Quipt Home Medical (QIPT) | United States | $0.075B | 0.00 |
Veru (VERU) | United States | $0.072B | 0.00 |
InterCure (INCR) | Israel | $0.071B | 0.00 |
Zynex (ZYXI) | United States | $0.070B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.064B | 0.00 |
Apyx Medical (APYX) | United States | $0.063B | 0.00 |
ImmuCell (ICCC) | United States | $0.056B | 0.00 |
Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
United Health Products (UEEC) | United States | $0.051B | 0.00 |
Modular Medical (MODD) | United States | $0.045B | 0.00 |
United-Guardian (UG) | United States | $0.037B | 12.94 |
Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
Safety Shot (SHOT) | United States | $0.028B | 0.00 |
Nephros (NEPH) | United States | $0.028B | 37.57 |
Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
INLIF (INLF) | $0.018B | 0.00 | |
Flora Growth (FLGC) | United States | $0.015B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
Senestech (SNES) | United States | $0.005B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |